Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedHb SS disease added under Resources and Genetic and Rare Diseases Information Center listed as a Resources reference.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1, indicating a minor version update in the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedFooter shows Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.1%

Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.